Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Free Cash Flow (2022 - 2025)

Prokidney (PROK) has disclosed Free Cash Flow for 4 consecutive years, with -$31.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow changed 0.47% to -$31.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$146.7 million, a 10.21% decrease, with the full-year FY2024 number at -$155.9 million, down 25.42% from a year prior.
  • Free Cash Flow was -$31.8 million for Q3 2025 at Prokidney, up from -$34.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$16.1 million in Q4 2022 to a low of -$51.7 million in Q3 2023.
  • A 4-year average of -$30.4 million and a median of -$30.7 million in 2025 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: plummeted 123.32% in 2023, then skyrocketed 38.81% in 2024.
  • Prokidney's Free Cash Flow stood at -$16.1 million in 2022, then tumbled by 67.77% to -$27.0 million in 2023, then plummeted by 84.3% to -$49.7 million in 2024, then surged by 36.0% to -$31.8 million in 2025.
  • Per Business Quant, the three most recent readings for PROK's Free Cash Flow are -$31.8 million (Q3 2025), -$34.5 million (Q2 2025), and -$30.7 million (Q1 2025).